Logo image of AIL.DE

AIR LIQUIDE SA (AIL.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:AIL - FR0000120073 - Common Stock

159.7 EUR
+0.44 (+0.28%)
Last: 12/18/2025, 7:00:00 PM
Fundamental Rating

5

Overall AIL gets a fundamental rating of 5 out of 10. We evaluated AIL against 70 industry peers in the Chemicals industry. AIL has an excellent profitability rating, but there are some minor concerns on its financial health. While showing a medium growth rate, AIL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year AIL was profitable.
AIL had a positive operating cash flow in the past year.
In the past 5 years AIL has always been profitable.
AIL had a positive operating cash flow in each of the past 5 years.
AIL.DE Yearly Net Income VS EBIT VS OCF VS FCFAIL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

AIL has a Return On Assets of 6.70%. This is in the better half of the industry: AIL outperforms 78.57% of its industry peers.
Looking at the Return On Equity, with a value of 13.49%, AIL is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
The Return On Invested Capital of AIL (9.87%) is better than 85.71% of its industry peers.
AIL had an Average Return On Invested Capital over the past 3 years of 9.47%. This is above the industry average of 6.86%.
The last Return On Invested Capital (9.87%) for AIL is above the 3 year average (9.47%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.7%
ROE 13.49%
ROIC 9.87%
ROA(3y)6.1%
ROA(5y)5.92%
ROE(3y)12.2%
ROE(5y)12.34%
ROIC(3y)9.47%
ROIC(5y)8.98%
AIL.DE Yearly ROA, ROE, ROICAIL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

The Profit Margin of AIL (12.22%) is better than 90.00% of its industry peers.
In the last couple of years the Profit Margin of AIL has grown nicely.
With an excellent Operating Margin value of 19.93%, AIL belongs to the best of the industry, outperforming 94.29% of the companies in the same industry.
AIL's Operating Margin has improved in the last couple of years.
AIL's Gross Margin of 63.01% is amongst the best of the industry. AIL outperforms 92.86% of its industry peers.
In the last couple of years the Gross Margin of AIL has remained more or less at the same level.
Industry RankSector Rank
OM 19.93%
PM (TTM) 12.22%
GM 63.01%
OM growth 3Y3.78%
OM growth 5Y2.86%
PM growth 3Y3.49%
PM growth 5Y3.62%
GM growth 3Y1.78%
GM growth 5Y0.07%
AIL.DE Yearly Profit, Operating, Gross MarginsAIL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AIL is creating some value.
AIL has about the same amout of shares outstanding than it did 1 year ago.
AIL has more shares outstanding than it did 5 years ago.
AIL has a better debt/assets ratio than last year.
AIL.DE Yearly Shares OutstandingAIL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
AIL.DE Yearly Total Debt VS Total AssetsAIL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

AIL has an Altman-Z score of 3.66. This indicates that AIL is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.66, AIL is in the better half of the industry, outperforming 75.71% of the companies in the same industry.
AIL has a debt to FCF ratio of 4.60. This is a neutral value as AIL would need 4.60 years to pay back of all of its debts.
The Debt to FCF ratio of AIL (4.60) is better than 78.57% of its industry peers.
AIL has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
AIL has a Debt to Equity ratio (0.47) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.6
Altman-Z 3.66
ROIC/WACC1.35
WACC7.33%
AIL.DE Yearly LT Debt VS Equity VS FCFAIL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 0.84 indicates that AIL may have some problems paying its short term obligations.
AIL has a worse Current ratio (0.84) than 85.71% of its industry peers.
A Quick Ratio of 0.61 indicates that AIL may have some problems paying its short term obligations.
AIL has a Quick ratio of 0.61. This is amonst the worse of the industry: AIL underperforms 84.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.61
AIL.DE Yearly Current Assets VS Current LiabilitesAIL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

AIL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.10%, which is quite good.
The Earnings Per Share has been growing by 11.55% on average over the past years. This is quite good.
The Revenue has decreased by -1.99% in the past year.
The Revenue has been growing slightly by 4.30% on average over the past years.
EPS 1Y (TTM)11.1%
EPS 3Y12.6%
EPS 5Y11.55%
EPS Q2Q%-4.88%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y5.06%
Revenue growth 5Y4.3%
Sales Q2Q%2.94%

3.2 Future

The Earnings Per Share is expected to grow by 10.46% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.92% on average over the next years.
EPS Next Y4.71%
EPS Next 2Y8.33%
EPS Next 3Y8.77%
EPS Next 5Y10.46%
Revenue Next Year0.5%
Revenue Next 2Y2.35%
Revenue Next 3Y3.29%
Revenue Next 5Y3.92%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AIL.DE Yearly Revenue VS EstimatesAIL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B
AIL.DE Yearly EPS VS EstimatesAIL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 25.47, the valuation of AIL can be described as expensive.
AIL's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.38, AIL is valued at the same level.
A Price/Forward Earnings ratio of 21.16 indicates a rather expensive valuation of AIL.
The rest of the industry has a similar Price/Forward Earnings ratio as AIL.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.83, AIL is valued at the same level.
Industry RankSector Rank
PE 25.47
Fwd PE 21.16
AIL.DE Price Earnings VS Forward Price EarningsAIL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

AIL's Enterprise Value to EBITDA is on the same level as the industry average.
AIL's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 33.61
EV/EBITDA 12.76
AIL.DE Per share dataAIL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
AIL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)5.4
PEG (5Y)2.21
EPS Next 2Y8.33%
EPS Next 3Y8.77%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.08%, AIL has a reasonable but not impressive dividend return.
AIL's Dividend Yield is comparable with the industry average which is at 2.49.
Compared to an average S&P500 Dividend Yield of 1.87, AIL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.08%

5.2 History

The dividend of AIL has a limited annual growth rate of 5.87%.
Dividend Growth(5Y)5.87%
Div Incr Years6
Div Non Decr Years6
AIL.DE Yearly Dividends per shareAIL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

AIL pays out 59.10% of its income as dividend. This is a bit on the high side, but may be sustainable.
AIL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP59.1%
EPS Next 2Y8.33%
EPS Next 3Y8.77%
AIL.DE Yearly Income VS Free CF VS DividendAIL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
AIL.DE Dividend Payout.AIL.DE Dividend Payout, showing the Payout Ratio.AIL.DE Dividend Payout.PayoutRetained Earnings

AIR LIQUIDE SA

FRA:AIL (12/18/2025, 7:00:00 PM)

159.7

+0.44 (+0.28%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-21 2025-10-21
Earnings (Next)02-19 2026-02-19/amc
Inst Owners28.13%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap92.39B
Revenue(TTM)27.06B
Net Income(TTM)3.31B
Analysts81.94
Price Target202.47 (26.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.08%
Yearly Dividend2.99
Dividend Growth(5Y)5.87%
DP59.1%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.38%
PT rev (3m)0.37%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.01%
EPS NY rev (3m)-1.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-0.39%
Valuation
Industry RankSector Rank
PE 25.47
Fwd PE 21.16
P/S 3.41
P/FCF 33.61
P/OCF 14.32
P/B 3.77
P/tB 10.1
EV/EBITDA 12.76
EPS(TTM)6.27
EY3.93%
EPS(NY)7.55
Fwd EY4.72%
FCF(TTM)4.75
FCFY2.98%
OCF(TTM)11.16
OCFY6.99%
SpS46.77
BVpS42.37
TBVpS15.81
PEG (NY)5.4
PEG (5Y)2.21
Graham Number77.32
Profitability
Industry RankSector Rank
ROA 6.7%
ROE 13.49%
ROCE 13.55%
ROIC 9.87%
ROICexc 10.27%
ROICexgc 16.67%
OM 19.93%
PM (TTM) 12.22%
GM 63.01%
FCFM 10.16%
ROA(3y)6.1%
ROA(5y)5.92%
ROE(3y)12.2%
ROE(5y)12.34%
ROIC(3y)9.47%
ROIC(5y)8.98%
ROICexc(3y)9.91%
ROICexc(5y)9.43%
ROICexgc(3y)16.92%
ROICexgc(5y)16.28%
ROCE(3y)12.5%
ROCE(5y)11.85%
ROICexgc growth 3Y3.94%
ROICexgc growth 5Y3.85%
ROICexc growth 3Y4.91%
ROICexc growth 5Y4.63%
OM growth 3Y3.78%
OM growth 5Y2.86%
PM growth 3Y3.49%
PM growth 5Y3.62%
GM growth 3Y1.78%
GM growth 5Y0.07%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.6
Debt/EBITDA 1.45
Cap/Depr 144.44%
Cap/Sales 13.69%
Interest Coverage 20.74
Cash Conversion 81.11%
Profit Quality 83.15%
Current Ratio 0.84
Quick Ratio 0.61
Altman-Z 3.66
F-Score7
WACC7.33%
ROIC/WACC1.35
Cap/Depr(3y)136.72%
Cap/Depr(5y)133.49%
Cap/Sales(3y)12.08%
Cap/Sales(5y)12.32%
Profit Quality(3y)89.94%
Profit Quality(5y)95.75%
High Growth Momentum
Growth
EPS 1Y (TTM)11.1%
EPS 3Y12.6%
EPS 5Y11.55%
EPS Q2Q%-4.88%
EPS Next Y4.71%
EPS Next 2Y8.33%
EPS Next 3Y8.77%
EPS Next 5Y10.46%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y5.06%
Revenue growth 5Y4.3%
Sales Q2Q%2.94%
Revenue Next Year0.5%
Revenue Next 2Y2.35%
Revenue Next 3Y3.29%
Revenue Next 5Y3.92%
EBIT growth 1Y6.37%
EBIT growth 3Y9.03%
EBIT growth 5Y7.28%
EBIT Next Year55.08%
EBIT Next 3Y21.79%
EBIT Next 5Y15.96%
FCF growth 1Y-11.79%
FCF growth 3Y1.77%
FCF growth 5Y6.15%
OCF growth 1Y-1.16%
OCF growth 3Y4.31%
OCF growth 5Y6.05%

AIR LIQUIDE SA / AIL.DE FAQ

What is the fundamental rating for AIL stock?

ChartMill assigns a fundamental rating of 5 / 10 to AIL.DE.


Can you provide the valuation status for AIR LIQUIDE SA?

ChartMill assigns a valuation rating of 3 / 10 to AIR LIQUIDE SA (AIL.DE). This can be considered as Overvalued.


How profitable is AIR LIQUIDE SA (AIL.DE) stock?

AIR LIQUIDE SA (AIL.DE) has a profitability rating of 9 / 10.


Can you provide the financial health for AIL stock?

The financial health rating of AIR LIQUIDE SA (AIL.DE) is 4 / 10.


What is the earnings growth outlook for AIR LIQUIDE SA?

The Earnings per Share (EPS) of AIR LIQUIDE SA (AIL.DE) is expected to grow by 4.71% in the next year.